Averatek Names New CEO

Estimated reading time: 1 minute

Averatek is pleased to announce Scott Meikle, Ph.D. as CEO. Dr. Meikle has more than 30 years of experience in the semiconductor industry. For the past six years he served as SVP - Global Customer Operations at Lam Research.  Lam is a leading manufacturer of semiconductor manufacturing equipment and semiconductor packaging products with over $17 Billion in revenue and 14,000 employees. Prior to Lam, Dr. Meikle was resident in Taiwan for 5 years serving as the President of Inotera Memories, a publicly listed company.  Dr. Meikle also worked for Micron, another semiconductor giant, for over 20 years in R&D, manufacturing, and executive positions.

There are exciting opportunities for Averatek: its flagship product is Liquid Metal Ink™, key chemistry for the Averatek Semi-Additive Process (A-SAP™).  This groundbreaking technology enables fine pitch metallization on a variety of traditional and novel substrate materials and has applications across a broad range of market sectors: medical, high-speed digital and ultra-high density interconnects for military, aerospace and commercial products. With unique capabilities that enable dramatic improvements in functionality and reliability, Averatek offerings have drawn the interest of major industry players, and are featured in contracts with the Department of Defense and other government agencies.

With expansion planned into the semiconductor market sector, Dr. Meikle will build out  the Averatek leadership team. His experience and extensive network across the electronics industry, from the United States and Europe to Asia, will be tremendously valuable in setting strategy and developing customer and partner relationships.

Outgoing CEO Haris Basit remains active as a Senior Advisor to the company.

Basit commented: “I am proud of our accomplishments during my six years, notably our progress in the PCB sector. I look forward to continuing my support of Averatek, its customers and partners. The Board and I are very enthusiastic about working with Dr. Meikle to bring Averatek to the next level."